EcoVadis Platinum Level Achieved in 2026
We have renewed our EcoVadis assessment and achieved the Platinum level!
April 11, 2025
The HTL Edge: Insights from Experts
Hear from experts on why the quality and origin of raw materials are important for the efficacy and safety of treatments in aesthetic medicine:
In this first interview, Dr. Abs Settipalli, an aesthetic medicine and biotechnology expert, talks about various topics concerning raw materials in aesthetic medicine such as:
- the crucial role of the quality and origin of raw materials in ensuring safety and efficacy of aesthetic treatments,
- the importance of the production process and quality control of hyaluronic acid as a raw material,
- HTL Biotechnology’s commitment to the process and why this makes it a strong criterion in choosing the right product for patients:
Next we have Dr. Tingsong Lim, a renowned aesthetic doctor from Malaysia, who talks about:
- the benefits of #Polynucleotides in aesthetic medicine,
- the importance of their origin and quality in guaranteeing the effectiveness and safety of injections,
- the significance of high-quality ingredients and HTL Biotechnology’s dedication to excellence in raw material production.
Finally, Dr. Nabila Azib, a leading aesthetic physician from Morocco, shares her valuable insights on:
- the critical factors to consider when selecting a dermal filler,
- the difference that raw materials make in the safety and efficacy of aesthetic treatments,
- how the choice of Premium raw materials can significantly impact treatment outcomes.
With strong expertise in the field, HTL Biotechnology is a leader in the development and manufacturing of premium quality biopolymers for medical aesthetics
Click on the link or contact our team to learn more about our biopolymers.
Feel the difference with HTL inside!
To see our most recent news,
follow us on LinkedIn
Read more
blog posts from us
-
September 2, 2026Biopolymers for Ophthalmic Drug Delivery: The Example of Ophthalmic Inserts in Glaucoma Treatment
Glaucoma is currently one of the leading causes of irreversible vision loss worldwide. This chronic disease is characterized by progressive damage to the optic nerve, with elevated intraocular pressure being the main modifiable risk factor for disease development and progression. Management relies on the daily administration of pressure-lowering treatments in the form of eye drops to slow disease progression. Although these treatments have demonstrated their efficacy, their long-term use remains challenged by a major issue: treatment adherence, due in part to the physiological limitations of conventional ocular drug administration.
In response to these limitations, the development of new ophthalmic drug delivery technologies aims to improve drug residence time in the eye and ensure a more consistent release of the active pharmaceutical ingredient. Among these innovations, ophthalmic inserts are emerging as a promising technology. [1]
-
July 15, 2026Three Biomolecules Driving the Future of Skin Quality
Skin quality has become one of the main focuses of modern aesthetic medicine. While traditional treatments have often aimed to correct visible signs of ageing, today’s regenerative approaches seek to improve the skin itself by supporting hydration, structure and tissue regeneration.
-
June 25, 2026Expert spotlight : Hyaluronic Acid cross-linking: A key determinant of filler performance
Hyaluronic acid (HA) has become the dominant biomaterial in injectable soft tissue augmentation, with millions of treatments performed annually worldwide. As a naturally occurring glycosaminoglycan composed of repeating disaccharide units of D-glucuronic acid and N-acetyl-D-glucosamine, native HA possesses exceptional biocompatibility, hygroscopicity, and viscoelastic properties. However, in its unmodified state, HA is rapidly degraded in vivo by endogenous hyaluronidases and reactive oxygen species, with a tissue half-life measured in hours to days. [1,2]
To overcome this limitation and create materials suitable for lasting soft tissue correction, HA must be chemically cross-linked. This process transforms a fluid polysaccharide solution into a structured hydrogel with tuneable mechanical and biological properties. The chemistry of cross-linking is, in many respects, the defining step that determines how a dermal filler will perform in the hands of a clinician and in the tissues of a patient. [2,3]